ArticleThe Journal of investigative dermatology2018

Survival of Second-Line Biologics in Psoriasis: The British BADBIR Registry Data Informs Daily Practice.

Alexander A Navarini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.